Neurohormonal and clinical sex differences in heart failure

European Heart Journal

Volumn 34, Issue 32, 2013, Pages 2538-2547

  Meyer, Sven ^a   Van Der Meer, Peter ^a   Van Deursen, Vincent M ^a   Jaarsma, Tiny ^b   Van Veldhuisen, Dirk J ^a   Van Der Wal, Martje H L ^a   Hillege, Hans L ^a   Voors, Adriaan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Aetiology; Biomarkers; Heart failure; Mortality; Sex

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 6; NEUROHORMONE; PENTRAXIN 3; SYNDECAN 1; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; CONFIDENCE INTERVAL; DEMOGRAPHY; FEMALE; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

AETIOLOGY; BIOMARKERS; HEART FAILURE; MORTALITY; SEX;

AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEUROTRANSMITTER AGENTS; PROGNOSIS; SEX CHARACTERISTICS;

EID: 84883160799     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht152     Document Type: Article

References (63)

1. Mehta PA, Cowie MR. Gender and heart failure: a population perspective. Heart 2006;92(Suppl. 3):iii14-8.
2. Lindenfeld J, Krause-Steinrauf H, Salerno J. Where are all the women with heart failure?. J Am Coll Cardiol 1997;30:1417-1419. (Pubitemid 27486455)
3. Heiat A, Gross CP, Krumholz HM. Representationofthe elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002;162:1682-1688.
4. Hsich EM, Pina IL. Heart failure in women: a need for prospective data. J Am Coll Cardiol 2009;54:491-498.
5. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effectofdigoxin for the treatment of heart failure. N Engl J Med 2002;347:1403-1411. (Pubitemid 35239712)
6. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Pina IL, Granger CB, Ostergren J, Michelson EL, Solomon SD, Pocock S, Yusuf S, Swedberg K, Pfeffer MA, CHARM Investigators. Sex differences in clinical characteristics and prognosisin a broad spectrum of patients with heart failure: results of the Candesar-tan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007;115:3111-3120. (Pubitemid 46956500)
7. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P. Sex differences in the progno-sisof congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2001;103:375-380. (Pubitemid 32105976)
8. Arshad A, Moss AJ, Foster E, Padeletti L, Barsheshet A, Goldenberg I, Greenberg H, Hall WJ, McNitt S, Zareba W, Solomon S, Steinberg JS, MADIT-CRT Executive Committee. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol 2011;57:813-820.
9. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-related differences inmyo-cardial remodeling. J Am Coll Cardiol 2010;55:1057-1065.
10. Jaarsma T, Van Der Wal MH, Hogenhuis J, Lesman I, Luttik ML, Veeger NJ, Van Veldhuisen DJ. Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluatingOutcomesofAdvising and CounsellinginHeart failure. Eur J Heart Fail 2004;6:227-233. (Pubitemid 38249367)
11. Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, van Gilst WH, Lok DJ, Dunselman PH, Tijssen JG, Hillege HL, van Veldhuisen DJ, Coordinating Study Evaluating Outcomesof Advising and Counseling in Heart Failure (COACH) Investigators. Effect of moderate or intensive disease management program on outcomein patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 2008;168:316-324. (Pubitemid 351281679)
12. Liu LC, Voors AA, van Veldhuisen DJ, van der Veer E, Belonje AM, Szymanski MK, Sillje HH, van Gilst WH, Jaarsma T, de Boer RA. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail 2011;13:619-625.
13. Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL, van Veldhuisen DJ. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 2011;13:1111-1120.
14. de Boer RA, Lok DJ, Jaarsma T, van der Meer P, Voors AA, Hillege HL, van Veldhuisen DJ. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 2011;43:60-68.
15. Radloff LS. The CES-D scale. A self-report depression scale for research in the general population. Psychol Meas Appl 1977;1:385-401.
16. Schroevers MJ, Sanderman R, van Sonderen E, Ranchor AV. The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual Life Res 2000;9: 1015-1029. (Pubitemid 32289939)
17. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Fail 1987;3:198-209.
18. Postmus D, van Veldhuisen DJ, Jaarsma T, Luttik ML, Lassus J, Mebazaa A, Nieminen MS, Harjola VP, Lewsey J, Buskens E, Hillege HL. The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure. Eur J Heart Fail 2012;14:168-175.
19. Vaccarino V, Chen YT, Wang Y, Radford MJ, Krumholz HM. Sex differences in the clinical care and outcomes of congestive heart failure in the elderly. Am Heart J 1999;138:835-842. (Pubitemid 29523269)
20. Galvao M, Kalman J, DeMarco T, Fonarow GC, Galvin C, Ghali JK, Moskowitz RM. Gender differences in in-hospital management and outcomes in patients with de-compensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Card Fail 2006;12:100-107. (Pubitemid 43340150)
21. Nieminen MS, Harjola VP, Hochadel M, Drexler H, Komajda M, Brutsaert D, Dickstein K, Ponikowski P, Tavazzi L, Follath F, Lopez-Sendon JL. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 2008;10:140-148. (Pubitemid 351221390)
22. Alla F, Al-Hindi AY, Lee CR, Schwartz TA, Patterson JH, Adams KF Jr. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction. Am Heart J 2007;153:1074-1080. (Pubitemid 46809847)
23. Ho JE, Gona P, Pencina MJ, Tu JV, Austin PC, Vasan RS, Kannel WB, D'Agostino RB, Lee DS, Levy D. Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J 2012;33:1734-41.
24. Tasevska-Dinevska G, Kennedy LM, Nilsson PM, Willenheimer R. Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmo preventive project. Eur J Epidemiol 2009;24:249-257.
25. Martinez-Selles M, Doughty RN, Poppe K, Whalley GA, Earle N, Tribouilloy C, McMurray JJ, Swedberg K, Kober L, Berry C, Squire I, on behalf of the Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC). Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail 2012;14:473-479.
26. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB Jr, Herrington DM. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006;152:593-598. (Pubitemid 44233418)
27. Yamasaki K, Kurimura M, Kasai T, Sagara M, Kodama T, Inoue K. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem Lab Med 2009;47:471-477.
28. Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis 2009;19:129-134.
29. de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P.The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 2011;272:55-64.
30. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002;90:254-258. (Pubitemid 34804560)
31. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W, Ponikowski P, Filippatos GS, Rozentryt P, Drexler H, Anker SD, Wollert KC. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 2007;50:1054-1060. (Pubitemid 47348231)
32. Stejskal D, Karpisek M, Humenanska V, Hanulova Z, Stejskal P, Kusnierova P, Petzel M. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. Horm Metab Res 2008;40:381-385. (Pubitemid 351967128)
33. Mercadal L, Metzger M, Casadevall N, Haymann JP, Karras A, Boffa JJ, Flamant M, Vrtovsnik F, Stengel B, Froissart M, NephroTest Study Group. Timing and determinants of erythropoietin deficiency in chronic kidney disease. Clin J Am Soc Nephrol 2012;7:35-42.
34. Marques-Vidal P, Bochud M, Bastardot F, Luscher T, Ferrero F, Gaspoz JM, Paccaud F, Urwyler A, von Kanel R, Hock C, Waeber G, Preisig M, Vollenweider P. Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study). PLoS One 2011;6:e21002.
35. Lin Y, Nakachi K, Ito Y, Kikuchi S, Tamakoshi A, Yagyu K, Watanabe Y, Inaba Y, Kazuo T, Jacc Study Group. Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults. Dis Markers 2009;27:23-28.
36. Rohatgi A, Patel P, Das SR, Ayers CR, Khera A, Martinez-Rumayor A, Berry JD, McGuire DK, deLemos JA. Association of growth differentiation factor-15 with coronary atherosclerosis and mortalityin ayoung, multiethnic population: observations from the Dallas Heart Study. Clin Chem 2012;58:172-182.
37. Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M. Age-and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 2007;72:632-637. (Pubitemid 47312796)
38. Lacher DA, Barletta J, Hughes JP. Biological variation of hematology tests based on the 1999-2002 National Health and Nutrition Examination Survey. Natl Health Stat Report 2012;54:1-10.
39. Du XJ, Fang L, Kiriazis H. Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms. Pharmacol Ther 2006; 111:434-475. (Pubitemid 43832006)
40. Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz Noppinger P, Kintscher U, Gustafsson JA, Regitz-Zagrosek V. Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 2010;298:R1597-R606.
41. Cavasin MA, Tao Z, Menon S, Yang XP. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 2004;75: 2181-2192. (Pubitemid 39127470)
42. Wu JC, Nasseri BA, Bloch KD, Picard MH, Scherrer-Crosbie M. Influence of sex on ventricular remodeling after myocardial infarction in mice. J Am Soc Echocardiogr 2003;16:1158-1162. (Pubitemid 37371660)
43. Pfeffer JM, Pfeffer MA, Fletcher P, Fishbein MC, Braunwald E. Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats. Am J Physiol 1982;242:H776-H784. (Pubitemid 12040779)
44. Jain M, Liao R, Podesser BK, Ngoy S, Apstein CS, Eberli FR. Influenceofgenderonthe response to hemodynamic overload after myocardial infarction. Am J Physiol Heart Circ Physiol 2002;283:H2544-H2550. (Pubitemid 35345961)
45. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 1998;32:1118-1125. (Pubitemid 28459608)
46. Rohde LE, Zhi G, Aranki SF, Beckel NE, Lee RT, Reimold SC. Gender-associated dif-ferencesinleft ventricular geometryinpatients with aortic valve diseaseand effect of distinct overload subsets. Am J Cardiol 1997;80:475-480. (Pubitemid 27371754)
47. Gardner JD, Brower GL, Janicki JS. Gender differencesin cardiac remodelingsecond-ary to chronic volume overload. J Card Fail 2002;8:101-107. (Pubitemid 34521420)
48. Brower GL, Gardner JD, Janicki JS. Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol Cell Biochem 2003;251:89-95. (Pubitemid 37220714)
49. Dent MR, Tappia PS, Dhalla NS. Gender differences in cardiac dysfunction and remodeling due to volume overload. J Card Fail 2010;16:439-449.
50. Saltevo J, Kautiainen H, Vanhala M. Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. Gend Med 2009;6:463-470.
51. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999;22:1971-1977. (Pubitemid 30433974)
52. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135.
53. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-186.
54. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL. The origins of age-related proinflammatory state. Blood 2005;105: 2294-2299. (Pubitemid 40387022)
55. Du XJ, Fang L, Kiriazis H. Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms. Pharmacol Ther 2006; 111:434-475. (Pubitemid 43832006)
56. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysi-ology, diagnosis, and treatment. Eur Heart J 2011;32:670-679.
57. AdamsKFJr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L, Koch G. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996;28:1781-1788. (Pubitemid 26426235)
58. Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 2003;42:2128-2134. (Pubitemid 37549897)
59. Gottlieb SS, Khatta M, Friedmann E, Einbinder L, Katzen S, Baker B, Marshall J, Minshall S, Robinson S, Fisher ML, Potenza M, Sigler B, Baldwin C, Thomas SA. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 2004;43:1542-1549. (Pubitemid 38561331)
60. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006;48:1527-1537. (Pubitemid 44528168)
61. Jiang W, Kuchibhatla M, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR, O'Connor CM. Relationship between depressive symptoms and longterm mortality in patients with heart failure. Am Heart J 2007;154:102-108. (Pubitemid 46920483)
62. Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, Watanabe M, Yao A, Hirata Y, Kazuma K, Nagai R. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction. J Cardiol 2012;60:23-30.
63. Johansson P, Lesman-Leegte I, Svensson E, Voors A, van Veldhuisen DJ, Jaarsma T. Depressive symptoms and inflammation in patients hospitalized for heart failure. Am Heart J 2011;161:1053-1059.